| |
Latest 10 SEC filings (by transaction date) for IOVA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 17/24 | Apr 15/24 | Vogt Frederick G | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -20,834 | |
Apr 17/24 | Apr 15/24 | Vogt Frederick G | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -8,851 | $11.89 |
Apr 17/24 | Apr 15/24 | Vogt Frederick G | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 20,834 | |
Apr 17/24 | Apr 15/24 | Graf Finckenstein Friedrich | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -2,812 | |
Apr 17/24 | Apr 15/24 | Graf Finckenstein Friedrich | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -1,427 | $11.89 |
Apr 17/24 | Apr 15/24 | Graf Finckenstein Friedrich | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,812 | |
Apr 17/24 | Apr 15/24 | Bilinsky Igor | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -2,812 | |
Apr 17/24 | Apr 15/24 | Bilinsky Igor | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -1,427 | $11.89 |
Apr 17/24 | Apr 15/24 | Bilinsky Igor | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,812 | |
Mar 6/24 | Mar 4/24 | Graf Finckenstein Friedrich | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -15,623 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for IOVA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 17/24 | Apr 15/24 | Vogt Frederick G | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -20,834 | |
Apr 17/24 | Apr 15/24 | Vogt Frederick G | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -8,851 | $11.89 |
Apr 17/24 | Apr 15/24 | Vogt Frederick G | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 20,834 | |
Apr 17/24 | Apr 15/24 | Graf Finckenstein Friedrich | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -2,812 | |
Apr 17/24 | Apr 15/24 | Graf Finckenstein Friedrich | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -1,427 | $11.89 |
Apr 17/24 | Apr 15/24 | Graf Finckenstein Friedrich | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,812 | |
Apr 17/24 | Apr 15/24 | Bilinsky Igor | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -2,812 | |
Apr 17/24 | Apr 15/24 | Bilinsky Igor | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -1,427 | $11.89 |
Apr 17/24 | Apr 15/24 | Bilinsky Igor | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,812 | |
Mar 6/24 | Mar 4/24 | Graf Finckenstein Friedrich | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -15,623 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Exact Sciences (OQ:EXAS) |
Adaptive Biotechnologies (OQ:ADPT) |
Veracyte (OQ:VCYT) |